Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.590
+0.020 (0.78%)
At close: Apr 28, 2026, 4:00 PM EDT
2.770
+0.180 (6.95%)
Pre-market: Apr 29, 2026, 8:02 AM EDT
Nautilus Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 328 | 246 | 211 | 374 | 225 | 643 | |
| Market Cap Growth | 228.51% | 16.76% | -43.55% | 66.44% | -65.09% | - | |
| Enterprise Value | 254 | 142 | 102 | 226 | -4 | 299 | |
| Last Close Price | 2.59 | 1.95 | 1.68 | 2.99 | 1.80 | 5.18 | |
| PB Ratio | 2.09 | 1.57 | 1.01 | 1.41 | 0.71 | 1.77 | |
| P/TBV Ratio | 2.09 | 1.57 | 1.01 | 1.41 | 0.71 | 1.77 | |
| Debt / Equity Ratio | 0.19 | 0.19 | 0.15 | 0.13 | 0.10 | 0.08 | |
| Net Debt / Equity Ratio | -0.47 | -0.47 | -0.48 | -0.52 | -0.49 | -0.87 | |
| Net Debt / EBITDA Ratio | 1.13 | 1.13 | 1.25 | 1.87 | 2.47 | 6.38 | |
| Net Debt / FCF Ratio | 1.41 | 1.41 | 1.60 | 2.56 | 3.20 | 7.61 | |
| Quick Ratio | 13.00 | 13.00 | 17.02 | 19.01 | 27.16 | 59.49 | |
| Current Ratio | 13.33 | 13.33 | 17.40 | 19.39 | 27.57 | 60.09 | |
| Return on Equity (ROE) | -32.27% | -32.27% | -29.86% | -21.95% | -17.07% | -22.75% | |
| Return on Assets (ROA) | -19.26% | -19.26% | -18.57% | -14.52% | -10.62% | -13.06% | |
| Return on Capital Employed (ROCE) | -36.50% | -36.50% | -34.70% | -25.70% | -18.50% | -12.90% | |
| Earnings Yield | -18.00% | -23.96% | -33.55% | -17.04% | -25.80% | -7.82% | |
| FCF Yield | -15.86% | -21.10% | -29.40% | -14.49% | -21.44% | -6.45% | |
| Buyback Yield / Dilution | -0.66% | -0.66% | -0.41% | -0.27% | -47.51% | -190.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.